Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Clinical - Phase I
ZIOPHARM, Inc. Announces Initiation of Phase 1b/2 Study of Ad-RTS-hIL-12 Gene Therapy in Patients With Locally Advanced or Metastatic Breast Cancer 4/27/2015 7:34:00 AM
Aratana Therapeutics (PETX) Comments On ADXS31-164 (AT-014) Study Data Presented During Poster Session At The AACR Annual Meeting 2015 4/27/2015 7:29:39 AM
aTyr Pharma Receives U.S. FDA Orphan Designation For Resolaris 4/27/2015 6:28:51 AM
EXCLUSIVE: Jounce CEO Says Funding Aims for Trials Next Year, Will Hire 10 4/24/2015 1:10:50 AM
GW Pharmaceuticals (GWPH) Receives Orphan Drug Designation From FDA For Cannabidiol For The Treatment Of Neonatal Hypoxic-Ischemic Encephalopathy 4/24/2015 7:33:48 AM
Merck & Co. (MRK)'s Keytruda Effective Against Three Cancers 4/20/2015 5:59:45 AM
Gilead (GILD)’s Hepatitis C Combo Shows Cure Rate of 93% At Six Weeks, Fails at Four 4/23/2015 11:26:24 AM
Nordic Nanovector: Results Of Phase 1 Study Of Betalutin In Patients With Non-Hodgkin Lymphoma To Be Presented At The International Conference On Malignant Lymphoma 4/23/2015 1:25:18 PM
INSYS Therapeutics Commences Dosing In Phase 1/2 Safety And Pharmacokinetic Study Of Cannabidiol Oral Solution In Pediatric Epilepsy Patients 4/23/2015 11:37:10 AM
Tisch MS Research Center Of New York Reports Early Improvement In Stem Cell Trial 4/23/2015 11:21:17 AM
CAR-T Cell Companies Juno Therapeutics (JUNO), Kite Pharma (KITE), and ZIOPHARM, Inc. Get Stock Jitters on Disappointing Novartis AG (NVS) Trial News 4/21/2015 6:39:03 AM
Triphase Accelerator Initiates Phase I Study Of Marizomib And Bevacizumab In Patients With Glioblastoma 4/22/2015 2:51:38 PM
Heat Biologics. To Present At The 2015 AACR Annual Meeting 4/22/2015 1:58:32 PM
Verastem, Inc. (VSTM) Presents Encouraging Scientific Data On The Preferential Targeting Of Cancer Stem Cells At The 2015 AACR Annual Meeting 4/22/2015 11:04:12 AM
Acorda Therapeutics (ACOR) Presents Data On First Clinical Study Of Remyelinating Antibody For Multiple Sclerosis At American Academy of Neurology Annual Meeting 4/22/2015 10:57:10 AM